GEN-MINOXIDIL LIQ 2% 2 % — DIN 02065800
MINOXIDIL : 2 % · GENPHARM ULC · LIQUID · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is GEN-MINOXIDIL LIQ 2%?
GEN-MINOXIDIL LIQ 2% 2 % contains MINOXIDIL : 2 %. It is listed in the Health Canada Drug Product Database under DIN 02065800, held by GENPHARM ULC, supplied as LIQUID for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 05-Aug-2009. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Minoxidil, Topical in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
9 holders have a Canadian DIN containing Minoxidil, Topical, across 16 DINs, of which 7 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| JOHNSON & JOHNSON INC | 3 | 3 | MEN'S ROGAINE, MEN'S ROGAINE FOAM 5%, WOMEN'S ROGAINE FOAM 5% | Sourceable in Canada |
| TARO PHARMACEUTICALS INC | 2 | 2 | MEN'S MINOXIDIL FOAM, WOMEN'S MINOXIDIL FOAM | Sourceable in Canada |
| VITA HEALTH PRODUCTS INC | 3 | 1 | HAIR REGROWTH FORMULA, HAIR REGROWTH TREATMENT, HAIRGRO | Sourceable in Canada |
| GLENMARK PHARMACEUTICALS CANADA INC. | 2 | 1 | MEN'S GLN-MINOXIDIL, WOMEN'S GLN-MINOXIDIL | Sourceable in Canada |
| APOTEX INC | 2 | 0 | APO-GAIN LIQ 20MG/ML, HAIR REGROWTH TREATMENT | No marketed DIN |
| ALTIMED PHARMA INC. | 1 | 0 | MINOXIGAINE TOPICAL SOLUTION - 2% | No marketed DIN |
| GENPHARM ULC | 1 | 0 | GEN-MINOXIDIL LIQ 2% | No marketed DIN |
| JAMP PHARMA CORPORATION | 1 | 0 | JAMP MINOXIDIL SOLUTION | No marketed DIN |
| LABORATOIRE RIVA INC. | 1 | 0 | MINOX | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 2 % |
|---|---|
| Dosage form | LIQUID |
| Route | TOPICAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Minoxidil, Topical |
|---|---|
| ATC code | D11AX01 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02065800 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2065800 |
| Brand name | GEN-MINOXIDIL LIQ 2% |
| Generic / active ingredient | MINOXIDIL : 2 % |
| Market authorization holder | GENPHARM ULC |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D11AX01 |
| ATC anatomical main group | D — Dermatologicals |
| ATC therapeutic subgroup | D11AX |
| Current status | CANCELLED POST MARKET |
| Status date | 05-Aug-2009 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
7 of 16 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| HAIR REGROWTH FORMULA | 20 MG | SOLUTION | VITA HEALTH PRODUCTS INC | MARKETED | 02356597 |
| MEN'S GLN-MINOXIDIL | 5 % | AEROSOL, FOAM | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED | 02553465 |
| MEN'S MINOXIDIL FOAM | 5 % | AEROSOL, FOAM | TARO PHARMACEUTICALS INC | MARKETED | 02551446 |
| MEN'S ROGAINE | 20 MG | SOLUTION | JOHNSON & JOHNSON INC | MARKETED | 00708925 |
| MEN'S ROGAINE FOAM 5% | 5 % | AEROSOL, FOAM | JOHNSON & JOHNSON INC | MARKETED | 02368684 |
| WOMEN'S MINOXIDIL FOAM | 5 % | AEROSOL, FOAM | TARO PHARMACEUTICALS INC | MARKETED | 02551659 |
| WOMEN'S ROGAINE FOAM 5% | 5 % | AEROSOL, FOAM | JOHNSON & JOHNSON INC | MARKETED | 02424703 |
| APO-GAIN LIQ 20MG/ML | 20 MG | SOLUTION | APOTEX INC | DORMANT | 00885754 |
| HAIR REGROWTH TREATMENT | 2 % | SOLUTION | APOTEX INC | APPROVED | 02460181 |
| HAIR REGROWTH TREATMENT | 2 % | SOLUTION | VITA HEALTH PRODUCTS INC | CANCELLED POST MARKET | 02242377 |
2 · Same class — other molecules in ATC D11AX
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Pyrithione Zinc | 2 IN 1 ANTI-DANDRUFF SHAMPOO AND CONDITIONER · 2 IN 1 CONDITIONING DANDRUFF SHAMPOO · 2 IN 1 CONDITIONING DANDRUFF TREATMENT SHAMPOO · 2 IN 1 DANDRUFF RELIEF SHAMPOO & CONDITIONER · +343 more | 363 | 67 | Yes |
| Finasteride | AURO-FINASTERIDE 1MG · FINASTERIDE · JAMP FINASTERIDE TABLETS · MINT-FINASTERIDE · +5 more | 10 | 8 | Yes |
| Minoxidil, Topical | APO-GAIN LIQ 20MG/ML · GEN-MINOXIDIL LIQ 2% · HAIR REGROWTH FORMULA · HAIR REGROWTH TREATMENT · +11 more | 16 | 7 | Yes |
| Ivermectin | PMS-IVERMECTIN · ROSIVER | 2 | 2 | Yes |
| Hydroquinone | ACTIVE 4 · AFRICAN GOLD SKIN DISCOLORATION FADE CRM 2% · AMBI EXTRA SKIN DISCOLORATION FADE CREAM · BANISHING CREAM · +63 more | 67 | 1 | Yes |
| Brimonidine | ONRELTEA | 1 | 1 | Yes |
| Eflornithine | VANIQA | 1 | 1 | Yes |
| Deoxycholic Acid | BELKYRA | 1 | 1 | Yes |
| Other Dermatologicals | DERMAGRAN II OINTMENT-ONT TOP 0.25% · SHUR-CLENS SOLN 20% · WITCH HAZEL | 3 | 0 | Not in Canada |
| Monobenzone | BENOQUIN CRM 20% | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC D11A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| D11AH | Abrocitinib · Alitretinoin · Crisaborole · Delgocitinib · Dupilumab · +5 more | 25 | 19 |
| D11AF | Wart And Anti-Corn Preparations | 33 | 1 |
| D11AA | Antihidrotics | 397 | 0 |
| D11AC | Cetrimide · Medicated Shampoos · Others · Povidone-Iodine · Selenium Compounds · +1 more | 27 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.